Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease.
Patients with known coronary disease and low-density lipoprotein >130 mg/dl who are followed by cardiologists after myocardial infarction are more than twice as likely to receive a cholesterol-lowering agent than patients followed by general internists.
Whyte
J J
JJ
Department of Medicine, Palo Alto VA Health Care System, California, USA.
Filly
A L
AL
Jollis
J G
JG
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002309:Cardiology; D015331:Cohort Studies; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy*; D005194:Family Practice; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control; D012189:Retrospective Studies
D000924:Anticholesteremic Agents